Finland· FI-REL-REL9392

Befral

A mibefradil product containing mibefradil dihydrochloride, registered in Finland by Orion Corporation Orion Pharma.

ATC C08CX01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedBefralATCC08CX01REGISTER NO.FI-REL-REL9392PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Mibefradil dihydrochloride
Manufacturer
Orion Corporation Orion Pharma
Country
Finland (FI)
ATC code
C08CX01
ATC class
Mibefradil
Defined daily dose
75 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9db8c192-31bf-4c45-a42e-30692cdf136f
GET /v1/drugs/9db8c192-31bf-4c45-a42e-30692cdf136f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "75",
  "form": "tabletti",
  "route": null,
  "ddd_unit": "mg",
  "strength": "50 mg",
  "atc_label": "mibefradiili",
  "ma_number": "12798",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL9392",
  "authorised_at": "1997-07-28"
}

See everything about mibefradil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.